Identifying viral antagonists of innate immunity and determining if they contribute 21 to pathogenesis is critical for developing effective strategies to control emerging viruses. 22 Previously, we reported that an endoribonuclease (EndoU) encoded by murine 23 coronavirus plays a pivotal role in evasion of host innate immune defenses in 24 macrophages. Here, we asked if the EndoU activity of porcine epidemic diarrhea 25 coronavirus (PEDV), which causes acute diarrhea in swine, plays a role in antagonizing 26 the innate response in porcine epithelial cells and macrophages, the sites of viral 27 replication. We constructed an infectious clone of PEDV-Colorado strain (icPEDV-wt) 28 and an EndoU-mutant PEDV (icPEDV-EnUmt) by changing the codon for a catalytic 29 histidine residue of EndoU to alanine (His226Ala). We found that both icPEDV-wt and 30 icPEDV-EnUmt propagated efficiently in interferon (IFN) deficient Vero cells. In contrast, 31 the propagation of icPEDV-EnUmt was impaired in porcine epithelial cells (LLC-PK1), 32 where we detected an early and robust transcriptional activation of type I and type III 33 IFNs. Infection of piglets with the parental Colorado strain, icPEDV-wt or icPEDV-
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indicated virus at a dose of 0.1 tissue culture infectious dose 50 (TCID 50 ) per cell. The 172 mRNA levels of IFN-, IFN-, PEDV nucleocapsid (N) gene, and porcine GAPDH gene 173 were evaluated using RT-qPCR at different hours post-infection (hpi) (8, 12, 24, and 32 174 hpi). We found that in icPEDV-wt-infected cells, the relative mRNA level of IFN- was 175 not significantly changed at the tested time points, and the IFN- mRNA was detected 176 at a low level until late time points of infection (24 and 32 hpi). In contrast, icPEDV-177 EnUmt infection activated an earlier and more robust IFN response, as revealed by 178 elevated levels of IFN- mRNA as early as 8 hpi, and IFN- at 24 hpi (Fig. 3C and D) . 179 We also evaluated viral replication by monitoring levels of PEDV N gene mRNA and 180 production of progeny virus. The N gene mRNA expression in icPEDV-EnUmt-infected 181 cells was significantly reduced at late times post-infection (24 and 32 hpi) ( Fig. 3E ). We 182 found a significantly reduced titer of icPEDV-EnUmt at 32 and 48 hpi, as compared to 183 icPEDV-wt ( Fig. 3F) . 184 To determine if the elevated IFN expression could stimulate robust activation of 185 an antiviral response, we evaluated the expression of ISGs and pro-inflammatory 186 cytokines in virus-infected PK-1 cells. As shown in Figure 4 , icPEDV-EnUmt infection 187 stimulated an earlier and more robust transcriptional activation of ISGs and pro-188 inflammatory cytokines as revealed by activation of ISG54, ISG15, 2'-5'-oligoadenylate 189 synthetase 1 (OAS1) and tumor necrosis factor alpha (TNF-) ( Fig. 4 A-D) . Taken nodes of infected animals (24) (25) (26) . PEDV has also been shown to infect primary porcine 196 alveolar macrophages (PAMs) in vitro, although replication is minimal in these cultured 197 cells (33) . Therefore, to determine if EndoU activity plays a role in controlling the IFN 198 response in primary macrophages, we infected PAMs with either icPEDV-wt or EnUmt at a dose of 0.1 TCID 50 per cell and assessed the mRNA levels of IFN-, and IFN-3. As shown in Figure 5 , we observed significantly elevated production of mRNA levels200-to 500-fold higher than mock-or icPEDV-wt-infected cells at 6 and 202 12 hpi, respectively ( Fig. 5A ). We also detected elevated levels of IFN- mRNA (Fig. 5B ) 203 in cells infected with the icPEDV-EnUmt as compared to the levels seen in icPEDV-wt-204 infected cells. The IFN-3 mRNA level was slightly elevated (2-fold) at 24 hpi in 205 icPEDV-EnUmt-infected cells, but there was no statistically significant difference 206 between WT-and EndoU mutant-infected PAMs (Fig. 5C ). We note that both EnUmt-infected PAMs exhibited minimal elevation (2-fold) of N gene expression at 24 208 hpi ( Fig. 5D ), consistent with very low levels of virus replication in cultured PAMs (33) . 209 We also found that mRNA levels of ISG54 and OAS1 were significantly increased in 210 icPEDV-EnUmt-infected PAMs compared to icPEDV-wt infection ( Fig. 5E and F) . These 211 results together indicate that EndoU activity antagonizes the type I IFN response during 212 PEDV infection in primary macrophages.
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Evaluating the pathogenesis of PEDV-Colorado parental strain, icPEDV-wt 214 and icPEDV-EnUmt in piglets. We compared the pathogenicity of the parental PEDV-215 piglets in a litter were orally inoculated with one of the three viruses (10 5 TCID 50 per pig).
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Piglets were monitored daily for clinical symptoms and daily rectal swabs were collected 218 to evaluate fecal shedding of virus particles. We found that all virus-inoculated piglets 219 manifested with diarrhea and exhibited similar clinical symptoms during the 7-day 220 experimental course, with the icPEDV-EnUmt-infected piglets exhibiting slightly reduced 221 clinical scores at days 3-5 ( Fig. 6A ). Interestingly, although icPEDV-EnUmt-inoculated 222 piglets exhibited a similar disease as the WT-infected animals, we found that the 223 icPEDV-EnUmt-infected piglets had significantly reduced viral shedding on days 3 and 6, 224 and trended toward reduced shedding at all time points tested ( Fig. 6B ). Importantly, 225 there was no mortality in the icPEDV-EnUmt infected piglets, compared to 50% (4/8) 226 and 62.5% (5/8) mortality in the icPEDV-wt or PEDV-Colorado parental strain infected 227 piglets, respectively ( Fig. 6C ). We performed histopathologic examination of sections of 228 the small intestine in six pigs from the PEDV parental strain infected group, seven pigs 229 from the icPEDV-EnUmt infected group and six pigs from the icPEDV-wt infected group.
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Lesions consisted of villus atrophy and fusion, accumulation of inflammatory cells within 231 the lamina propria, primarily lymphocytes and plasma cells, and crypt hyperplasia.
232
Mucosal epithelium in affected sections of intestine was cuboidal to tall columnar and 233 there was mild exocytosis of inflammatory cells. Lesions were present in one or more 234 intestinal sections from all affected pigs, and were most pronounced within sections of 235 jejunum and ileum. We report that lesion severity was not significantly different in 236 affected pigs between the three virus-infected groups; however, individual variation was 237 observed in all groups. Representative images of ileum sections from an age-matched, animals, we performed immunohistochemistry to detect PEDV nucleocapsid protein.
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Similar to previous studies (24-26), viral antigen was detected in epithelial cells, and we 242 found that the sites of replication of the engineered viruses were essentially identical to Our study reveals that coronaviruses encode a highly conserved enzyme, EndoU, 247 that mitigates type I and type III IFN responses in virus-infected macrophages and 248 epithelial cells. By constructing an infectious clone of the virulent Colorado strain of 249 PEDV, and an isogenic strain with a mutation that inactivated EndoU activity, we could 250 directly compare the replication kinetics and innate immune responses of these two 251 viruses in cell culture and in animals. Consistent with previous studies of murine 252 coronavirus (12, 13), we found that both wild-type and the EndoU-mutant PEDV 253 replicate efficiently in interferon deficient Vero cells. However, the loss of EndoU activity 254 correlated with activation of type I (IFN-/) and type III (IFN-) IFN responses in 255 macrophages and epithelial cells, and reduced viral titer in PK-1 cells. These results are 256 also in line with previous reports indicating that replication of SARS-CoV is enhanced in 257 mice lacking the IFN- receptor (34, 35) , and that PEDV replication can be inhibited by 258 treatment of IFN-in epithelial cells (36, 37) . Overall, these studies illustrate the critical 259 role of IFNs in controlling enteric pathogens, and that coronaviruses have evolved 260 mechanisms to evade these host innate immune defenses.
Our study illustrates that the innate immune response to PEDV is cell type 262 specific, with macrophages responding via IFN-/ response, whereas the epithelial cell were recovered in the cuvette for 10 min at room temperature and then were cultured in 393 a 75-cm 2 flask in growth medium at 37°C and 5% CO 2 . The growth medium was 394 replaced with FCS-free maintenance medium containing 2 μg/mL TPCK-treated trypsin Table 1 . Growth kinetics of parental strain, wild-type, and EndoU mutant PEDV in Vero cells.
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Supernatants from infected cells were collected at indicated time points and titered on 723 Vero cells. TCID 50 was calculated using the Reed-Muench method (58). 10  20  30  40  50  60  70  80  90  100  1   110  120  130  140  150  160  170   180  190  200  210  220  230  240  250   330  320  310  300  290  280  270 
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